大同機械(00118.HK)悉售印刷線路板業務 料錄虧損5,200萬元
大同機械(00118.HK)公布,其間接非全資附屬邦基實業(控股),以代價1港元及1.37億元人民幣,向敖大德旗下的安(柏)線路板及鶴山安柏電路版廠,出售香港邦基股份及深圳邦基全部股本。集團預期將就出售事項錄得虧損約5,200萬港元。
公司預期出售事項所得款項淨額約5,000萬元人民幣,擬用於日常營運資金及/或任何可能存在的未來投資機會的資金。
香港邦基的主要業務為印刷線路板貿易,而深圳邦基的主要業務為印刷線路板加工。
公司指出,面對困難及多變的市場環境,出售事項為集團提供退出印刷線路板製造業務的機會,並讓集團將資源集中於更具正面現金流潛力的其他業務板塊,從而增強集團的財務狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.